Tissue-agnostic drug approvals: how does this apply to patients with breast cancer?
e-ESO Podcasts - En podcast af ESO - European School of Oncology
Kategorier:
Expert: Luiza Weis, Cancer Institute of Brasilia - ICB, Brasília, Brazil
e-ESO Podcasts - En podcast af ESO - European School of Oncology
Expert: Luiza Weis, Cancer Institute of Brasilia - ICB, Brasília, Brazil
